Astellas Pharma Europe Limited
Astellas Files Regulatory Submission for EC905 - A New Fixed Dose Combination Treatment for Male LUTS
Staines, England (ots/PRNewswire) - ASTELLAS PHARMA EUROPE Ltd., the European subsidiary of Tokyo - based Astellas Pharma Inc. today announced the submission of a Market Authorisation Application for EC905 in the Netherlands. This application for approval is the first step of the European-wide mutual recognition ...